Stephen Stefani

TL;DR: In this article, the authors present the findings of their Cancer Commission and their recommendations to encourage Latin American stakeholders to redouble their efforts to address this increasing cancer burden and to prevent it from worsening and threatening their societies.

TL;DR: The major challenges to the implementation of precision oncology are outlined and critical steps toward resolving these are discussed, including facilitation of equal access to genomics tests, ensuring that clinical studies provide robust evidence for new drugs and technologies, and enabling physicians to interpret genomics data.

TL;DR: The authors in this paper summarized progress in several aspects of cancer control since 2015, and identified persistent barriers requiring commitment of additional resources to reduce the cancer burden in Latin America and the Caribbean.

TL;DR: It seems entirely possible that, despite many intrinsic economic and political problems, Brazil can readily emerge as a model for other countries in Latin America for the potential benefits of precision medicine and companion diagnostics.